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“…they have all one language; and this they begin to do: and now nothing will be restrained 27 
from them, which they have imagined to do. Go to, let us go down, and there confound their 28 
language, that they may not understand one another's speech.” 29 
Genesis, Chapter 11, verses 6-7 30 
 31 
In the book of Genesis a spiteful God replaces a single, unifying language with a diversity of 32 
different ones, removing at a stroke mankind’s ability to work together towards a common goal. 33 
We believe that the Tower of Babel myth has clear relevance to the snake venom literature, 34 
particularly to the nomenclature of snake venom toxins.  35 
An established nomenclatural system for human genes, administered by the Human Genome 36 
Organisation (HUGO) Gene Nomenclature Committee (HGNC), has existed since 1979 (Shows 37 
et al., 1979) and similar systems also exist for mice (administered by the International 38 
Committee on Standardized Genetic Nomenclature for Mice) and zebrafish (administered by the 39 
Zebrafish Nomenclature Committee (ZNC)), as well as various other animal models. As a result, 40 
orthology, paralogy and the evolutionary relationships of these genes are clear for all to see. A 41 
nomenclatural committee was established by the International Society on Toxinology (IST) in 42 
1992 after several exchanges in the ‘Letters to the Editor’ section of Toxicon in the early 1990’s 43 
(Aird, 1990, Kaiser, 1990, Kumar et al., 1990), and more recently there have been suggestions 44 
for rational nomenclatural systems in spiders (King et al., 2008), scorpions (Tytgat et al., 1999), 45 
sea anemones (Oliveira et al., 2012) and centipedes (Undheim et al., 2014). However, despite 46 
over 20 years of asking, a nomenclatural system for reptile toxins has still not been established.  47 
The lack of widely-accepted, unifying standards for the nomenclature of snake venom toxins 48 
has resulted in huge diversity and disparity in the literature. In most cases the names assigned 49 
provide no insight into the evolutionary origins or relationships of the toxins, complicating 50 
comparative studies of venom composition, function or evolution both within and between 51 
species. For example, the similar sounding ophanin (accession AY181984, (Yamazaki et al., 52 
2003)), opharin (accession AY299475, Direct submission) and ohanin (accession DQ103590, 53 
(Pung et al., 2005)) from the king cobra (Ophiophagus hannah) are members of two different 54 
gene families – ophanin and opharin are cysteine-rich secretory proteins (CRISPs) and ohanin 55 
is a vespryn-like gene. Conversely, the differently sounding pseutarin C from Pseudonaja textilis 56 
(accession AY260939, (Rao et al., 2004)) and trocarin D from Tropidechis carinatus (accession 57 
DQ017707, (Reza et al., 2007)) are both coagulation factor X genes and barietin from Bitis 58 
arietans (accession FJ554635, (Yamazaki et al., 2009)), apiscin from Agkistrodon piscivorus 59 
(accession FJ554636, (Yamazaki et al., 2009)) and cratrin from Crotalus atrox (accession 60 
FJ554637, (Yamazaki et al., 2009)) are all vascular endothelial growth factor F (vegf-f) genes. 61 
The snake venom literature is replete with further examples, all of which obscure the 62 
relationships and functions of the toxins themselves – who would imagine that “cobra venom 63 
factor” which has been known since the late 19th century (Vogel, 1991) is part of the 64 
complement system from its name alone? Indeed, we have recently shown (Hargreaves et al., 65 
2014a) that the complement c3 gene has in fact been duplicated in cobras, giving rise to cobra 66 
venom factor, which should more accurately be called complement c3b to reflect its true 67 
evolutionary history. 68 
We have previously suggested (Hargreaves et al., 2014b) that the “evolutionary characterization 69 
code” proposed by the Anolis Gene Nomenclature Committee (AGNC) for lizards of that genus 70 
(Kusumi et al., 2011) should be applied to snake venom toxins, and we reiterate that suggestion 71 
here.  Full details of this classification code can be found in the relevant reference (Kusumi et 72 
al., 2011), but we provide a brief summary of some of the most relevant points below: 73 
 Gene symbols should be written completely in lower case and in italics, for example 74 
“gene2”. 75 
 Punctuation (dashes, periods, slashes) should not be used unless they are part of a 76 
human or mouse gene symbol. 77 
 Whenever orthology can be assigned, this should be present in the gene name, for 78 
example if the human gene symbol is “GENE2” then the reptile gene symbol would be 79 
“gene2”. 80 
 If an orthologous gene cannot be identified in any currently sequenced genome, a novel 81 
name may be selected by the investigators. 82 
 Gene symbols should not start with letters to indicate genus/species. 83 
 Gene duplicates should be assigned the suffix “a” or “b” to indicate them as being 84 
paralogs, e.g. gene2a and gene2b. 85 
In addition, we would suggest that where toxins are known only from peptide or protein 86 
sequences, without accompanying characterized gene sequences, they should be named on 87 
the basis of similarity to existing toxins using the suffix “–like” or be acknowledged as 88 
uncharacterized toxins. We should not shy away from acknowledging our ignorance, nor from 89 
presenting challenges to future researchers. That being said, it seems likely that the availability 90 
of genomic and transcriptomic data from an ever-growing range of species (see next section) 91 
will go at least some way to facilitating the identification of toxins in proteomic studies. 92 
With the recent publication of the whole genome sequences of two species of snake (the 93 
Burmese python Python molurus bivittatus and the king cobra, Ophiophagus hannah (Castoe et 94 
al., 2013,Vonk et al., 2013)), ongoing projects for several more (Castoe et al., 2011) and 95 
increasing amounts of transcriptomic data becoming available for a wide variety of species it is 96 
now more important than ever that these data are made as easily accessible, understandable 97 
and useable as possible. Whilst we appreciate the historical nature of the names of many snake 98 
venom toxins and do not argue that their sometimes rich history should be neglected, we must 99 
also consider the needs of the present and the future. The field of snake venom research should 100 
not distance itself from the rest of biology via the continued use of non-standardized 101 
nomenclature. If we want to facilitate collaboration with those from other research fields it is 102 
important that we all speak the same language – only then can we work together to better 103 
understand the origins and evolution of snake venom; its composition and function and its 104 
possible utility in the development of novel therapeutics. 105 
We note that Toxicon, unlike many other journals, does not currently suggest or enforce a 106 
standard nomenclature of genes reported in its papers. We therefore respectfully suggest that 107 
the Editors of this journal are well-placed to lead the way in the acquisition and development of 108 
a standardized nomenclatural system for snake venom toxins (and, indeed, for the toxins of 109 
other venomous animals). After all, what is the point of being an Editor if you can’t play God 110 
once in a while? 111 
 112 
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